Long‐term stroke risk in children with sickle cell disease screened with transcranial doppler

Stroke is an important complication of sickle cell disease. Stroke prediction is clinically important because it offers the possibility of primary prevention. In 1992, transcranial Doppler (TCD) evidence of elevated intracranial internal carotid or middle cerebral artery velocity was demonstrated to be associated strongly with an increased risk of ischemic stroke. This study extends the original study and includes 125 more children, longer follow‐up, and intracranial hemorrhage in the stroke‐risk model. Elevated time averaged mean maximum blood flow velocity, especially when velocity is 200 cm/sec or greater by TCD, was associated strongly with stroke risk. The cases not predicted by TCD point to the need for more information on the optimal timing of TCD surveillance for stroke risk.

[1]  R J Adams,et al.  Alpha thalassemia and stroke risk in sickle cell anemia , 1994, American journal of hematology.

[2]  C. Glasier,et al.  Cerebrovascular disease in symptomatic and asymptomatic patients with sickle cell anemia: screening with duplex transcranial Doppler US--correlation with MR imaging and MR angiography. , 1993, Radiology.

[3]  M. Sano,et al.  Abnormal cranial magnetic resonance imaging scans in sickle-cell disease. Neurological correlates and clinical implications. , 1993, Archives of neurology.

[4]  R. Adams,et al.  Transcranial Doppler Correlation With Cerebral Angiography in Sickle Cell Disease , 1992, Stroke.

[5]  J. Morris,et al.  Stroke in a cohort of patients with homozygous sickle cell disease. , 1992, The Journal of pediatrics.

[6]  R. Adams,et al.  The use of transcranial ultrasonography to predict stroke in sickle cell disease. , 1992, The New England journal of medicine.

[7]  K. Ohene‐Frempong.  Stroke in sickle cell disease: demographic, clinical, and therapeutic considerations. , 1991, Seminars in hematology.

[8]  W. Schroeder,et al.  Beta S-gene-cluster haplotypes in sickle cell anemia: clinical implications. , 1990, The American journal of pediatric hematology/oncology.

[9]  I. Prohovnik,et al.  Neurologic complications of sickle cell disease. , 1989, Advances in pediatrics.

[10]  H. Wieland,et al.  High-performance liquid chromatographic separation of human haemoglobins. Simultaneous quantitation of foetal and glycated haemoglobins. , 1988, Journal of chromatography.

[11]  S. Rothman,et al.  Sickle cell anemia and central nervous system infarction: A neuropathological study , 1986, Annals of neurology.

[12]  R. E. Perry,et al.  High-performance liquid chromatographic separation and quantitation of glycosylated hemoglobin A2 as an alternate index of glycemic control. , 1986, Journal of chromatography.

[13]  D. Cox,et al.  Analysis of Survival Data. , 1985 .

[14]  R. Aaslid,et al.  Noninvasive transcranial Doppler ultrasound recording of flow velocity in basal cerebral arteries. , 1982, Journal of neurosurgery.

[15]  C. Pegelow,et al.  The natural history of stroke in sickle cell disease. , 1978, The American journal of medicine.

[16]  J. Stockman,et al.  Occlusion of large cerebral vessels in sickle-cell anemia. , 1972, The New England journal of medicine.

[17]  J. Herion,et al.  Neurological manifestations in sickle-cell disease, with a review of the literature and emphasis on the prevalence of hemiplegia. , 1972, Annals of internal medicine.

[18]  M. Greer,et al.  Abnormal hemoglobin as a cause of neurologic disease , 1962, Neurology.

[19]  W. Bridgers.  Cerebral vascular disease accompanying sickle cell anemia. , 1939, The American journal of pathology.